Bioworld by clarivate rethinks obesity in new special investigation, finding fitness may be more linked to health than weight

In-depth analysis of obesity highlights latest advances in weight loss drugs, the search for biological fitness mediators and the pros and cons of weight as a proxy for health london , feb. 6, 2023 /prnewswire/ -- bioworld™ published by clarivate plc (nyse:clvt), a global leader in connecting people and organizations to intelligence they can trust to transform their world, explores how difficult scientific detachment can be for health topics that have large cultural components- such as obesity. after many years of research and development, drug-induced weight loss has matured into a viable therapeutic option.
CLVT Ratings Summary
CLVT Quant Ranking